OR for developing DLB or AD relative to APOEε2 and APOEε4 alleles adjusted for age and gender
| DLB vs CTR | AD vs CTR | |
|---|---|---|
| No. of APOE alleles | ||
| 1 or 2 APOE ε2 alleles | ||
| OR | 0.4 | 0.5 |
| CI | 0.3 to 0.8 | 0.4 to 0.8 |
| p Value | 0.004 | <0.0005 |
| 1 APOE ε4 allele | ||
| OR | 2.9 | 4.2 |
| CI | 2.2 to 4.6 | 3.2 to 5.4 |
| p Value | <0.0005 | <0.0005 |
| 2 APOE ε4 alleles | ||
| OR | 5.9 | 15.2 |
| CI | 2.7 to 13.0 | 8.5 to 27.2 |
| p Value | <0.0005 | <0.0005 |
AD, Alzheimer's disease; CTR, healthy controls; DLM, dementia with Lewy bodies.